Loading...
Tekla Healthcare Investors
HQH•NYSE
Financial Services
Asset Management
$15.90
$0.25(1.60%)
Tekla Healthcare Investors (HQH) AI-Powered Stock Analysis
See how Tekla Healthcare Investors scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerTekla Healthcare Investors (HQH) Stock Overall Grade
Tekla Healthcare Investors’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
B+
Good
Grade Breakdown by Metric
See how each financial and market factor contributes to Tekla Healthcare Investors's overall stock rating.
Forecast
B+Score
70/100Financial Growth
B+Score
70/100Fundamental Growth
B+Score
71/100Key Ratios
AScore
82/100Sector Comparison
A+Score
100/100Industry Comparison
A+Score
90/100S&P 500 Benchmark
AScore
85/100Analyst Consensus
C+Score
50/100Tekla Healthcare Investors (HQH) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 70/100 (B+), reflecting high confidence in its potential. Financial Growth (70/100, B+) and Fundamental Growth (71/100, B+) highlight its stability, while Key Ratios (82/100, A) and Sector Comparison (100/100, A+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (85/100, A), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Tekla Healthcare Investors stock grade, including financials, comparisons, and forecasts.